Got it! Thanks!
My estimate is at least $1.00 within weeks of going Pink Current like what happened to ENZ*C, keeping in mind that unlike ENZ*C, RBGP has a licensed patent in play that just got FDA Approval for entering Phase-1 Clinical Trials and is now officially a revenue generating company, so it should do very well both short and long term.
By end of this year, I expect to see a PPS North of $1.25 and I believe I'm being conservative with this estimate. Keep in mind the Market looks mainly forward which is what trading at multiples of actual earnings is about on the Major Exchanges.
If RGBP get's bought out by a Big Pharma along ALL of its 20+ Disruptive Biotechnology Patents, including the current one soon to enter clinical trials, I believe an offer will come in at $1.50 to $2.50 per share, if not it would likely be very close to this, AGAIN keep in mind the Multi-Billion Dollar Market Capacity of all the Patents combined this company holds and Koos is right now in the process of reviving many of them likely preparing to sell the company IMO as this would be a major "shoe in" for any Big Pharma for reason as such patents would go directly into an acquiring Big Pharma's clinical trials pipeline putting them way ahead of the competition! This requires investors in this sector to adopt the mind set of how leadership at Big Pharma's think, and I'm telling you and everyone here this is precisely how ALL of them think!
The BIG PICTURE HERE IS there's simply is NO BioTech/BioPharma Company on any Stock Exchange that has what this company has, not by a long shot and if so, I'd like to know who??
Again, all the above is only my personal opinion but I believe it is a qualified one due to me being a career clinical trials Physician for more than 30+ years that has seen what can and does happen when technology like this is development and transitions into the clinical trials phase and beyond!
RGBP is following the same pattern as any Bio-Pharma in its early development, and to me this means it's just a matter of time before they get bought out by one of several Big Pharmas that are known to be "cut throat" competitive with each other with a prime directive to own Patents of other Companies worth Billions and ANY small company like RGBP that's "Patent Rich" is the exact type of company that get's bought out by one of the majors who have Billions to spend. I'm just saying, that's all as this is a very typical senario that I have seen play out MANY TIMES in my career only RGBP has more Patents to their name than I have ever seen previously for a company of their size. It's absolutely astonishing what they have and the sector they are in with their mRNA biotechnology which is very clearly the future of medicine.
I hope this helps...and it's only an opinion!
Be well and prosper....
